Ibrahim Nassour1, Sam C Wang1,2, Matthew R Porembka1,2, Adam C Yopp1,2, Michael A Choti1,2, Mathew M Augustine1,2, Patricio M Polanco1,2, John C Mansour1,2, Rebecca M Minter3,4,5. 1. Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA. 2. University of Texas Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, TX, 75390, USA. 3. Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA. Rebecca.Minter@UTSouthwestern.edu. 4. University of Texas Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, TX, 75390, USA. Rebecca.Minter@UTSouthwestern.edu. 5. Division of Surgical Oncology, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-9031, USA. Rebecca.Minter@UTSouthwestern.edu.
Abstract
BACKGROUND: An increasing body of literature is supporting the safety of minimally invasive pancreaticoduodenectomy compared to open pancreaticoduodenectomy, but there are limited comparative studies between laparoscopic and robotic pancreaticoduodenectomy. The aim of this study was to compare the rate of postoperative 30-day overall complications between laparoscopic and robotic pancreaticoduodenectomy. METHODS: Patients who underwent laparoscopic and robotic pancreaticoduodenectomy were abstracted from the 2014-2015 pancreas-targeted American College of Surgeons National Surgical Quality Improvement Program. A multivariable logistic regression model was developed to determine if the type of minimally invasive approach was associated with 30-day overall complications. RESULTS: We identified 428 minimally invasive pancreaticoduodenectomy cases, of which 235 (55%) were performed laparoscopically and 193 (45%) robotically. Patients who underwent the robotic approach were more likely to be white compared to those who underwent the laparoscopic approach and were less likely to have pulmonary disease, undergo preoperative radiotherapy, and have vascular and multivisceral resection. On multivariable analysis, we found that the type of minimally invasive approach, whether laparoscopic or robotic, was not associated with overall complications. The predictors of 30-day overall complications were higher body mass index (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.02-1.09), vascular resection (OR, 2.10; 95% CI, 1.23-3.58), and longer operative time (OR, 1.002; 95% CI, 1.001-1.004). CONCLUSIONS: Robotic pancreaticoduodenectomy was associated with a similar 30-day overall complication rate to laparoscopic pancreaticoduodenectomy. Further studies are needed to corroborate these findings and to establish the best approach to perform this complex operation.
BACKGROUND: An increasing body of literature is supporting the safety of minimally invasive pancreaticoduodenectomy compared to open pancreaticoduodenectomy, but there are limited comparative studies between laparoscopic and robotic pancreaticoduodenectomy. The aim of this study was to compare the rate of postoperative 30-day overall complications between laparoscopic and robotic pancreaticoduodenectomy. METHODS:Patients who underwent laparoscopic and robotic pancreaticoduodenectomy were abstracted from the 2014-2015 pancreas-targeted American College of Surgeons National Surgical Quality Improvement Program. A multivariable logistic regression model was developed to determine if the type of minimally invasive approach was associated with 30-day overall complications. RESULTS: We identified 428 minimally invasive pancreaticoduodenectomy cases, of which 235 (55%) were performed laparoscopically and 193 (45%) robotically. Patients who underwent the robotic approach were more likely to be white compared to those who underwent the laparoscopic approach and were less likely to have pulmonary disease, undergo preoperative radiotherapy, and have vascular and multivisceral resection. On multivariable analysis, we found that the type of minimally invasive approach, whether laparoscopic or robotic, was not associated with overall complications. The predictors of 30-day overall complications were higher body mass index (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.02-1.09), vascular resection (OR, 2.10; 95% CI, 1.23-3.58), and longer operative time (OR, 1.002; 95% CI, 1.001-1.004). CONCLUSIONS: Robotic pancreaticoduodenectomy was associated with a similar 30-day overall complication rate to laparoscopic pancreaticoduodenectomy. Further studies are needed to corroborate these findings and to establish the best approach to perform this complex operation.
Authors: Camilo Correa-Gallego; Helen E Dinkelspiel; Isabel Sulimanoff; Sarah Fisher; Eduardo F Viñuela; T Peter Kingham; Yuman Fong; Ronald P DeMatteo; Michael I D'Angelica; William R Jarnagin; Peter J Allen Journal: J Am Coll Surg Date: 2013-11-23 Impact factor: 6.113
Authors: Ibrahim Nassour; Sam C Wang; Alana Christie; Mathew M Augustine; Matthew R Porembka; Adam C Yopp; Michael A Choti; John C Mansour; Xian-Jin Xie; Patricio M Polanco; Rebecca M Minter Journal: Ann Surg Date: 2018-07 Impact factor: 12.969
Authors: Matthew T McMillan; Amer H Zureikat; Melissa E Hogg; Stacy J Kowalsky; Herbert J Zeh; Michael H Sprys; Charles M Vollmer Journal: JAMA Surg Date: 2017-04-01 Impact factor: 14.766
Authors: Kristopher P Croome; Michael B Farnell; Florencia G Que; K Marie Reid-Lombardo; Mark J Truty; David M Nagorney; Michael L Kendrick Journal: Ann Surg Date: 2014-10 Impact factor: 12.969
Authors: Anne M Suskind; Shoujun Zhao; W John Boscardin; Alexander Smith; Emily Finlayson Journal: J Am Geriatr Soc Date: 2020-01-25 Impact factor: 5.562
Authors: James R Howe; Nipun B Merchant; Claudius Conrad; Xavier M Keutgen; Julie Hallet; Jeffrey A Drebin; Rebecca M Minter; Terry C Lairmore; Jennifer F Tseng; Herbert J Zeh; Steven K Libutti; Gagandeep Singh; Jeffrey E Lee; Thomas A Hope; Michelle K Kim; Yusuf Menda; Thorvardur R Halfdanarson; Jennifer A Chan; Rodney F Pommier Journal: Pancreas Date: 2020-01 Impact factor: 3.327
Authors: Richard S Hoehn; Ibrahim Nassour; Mohamed A Adam; Sharon Winters; Alessandro Paniccia; Amer H Zureikat Journal: J Gastrointest Surg Date: 2020-04-20 Impact factor: 3.452
Authors: Ibrahim Nassour; Michael A Choti; Matthew R Porembka; Adam C Yopp; Sam C Wang; Patricio M Polanco Journal: Surg Endosc Date: 2017-12-26 Impact factor: 4.584
Authors: Caitlin A Hester; Ibrahim Nassour; Alana Christie; Mathew M Augustine; John C Mansour; Patricio M Polanco; Matthew R Porembka; Thomas H Shoultz; Sam C Wang; Adam C Yopp; Herbert J Zeh; Rebecca M Minter Journal: Surg Endosc Date: 2019-04-23 Impact factor: 4.584
Authors: Jae Pil Jung; Mazen S Zenati; Mashaal Dhir; Amer H Zureikat; Herbert J Zeh; Richard L Simmons; Melissa E Hogg Journal: JAMA Surg Date: 2018-10-01 Impact factor: 14.766